Strand Life Sciences expands sequencing facility
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India
The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
Marks the World Head & Neck Cancer Day at the OCTF Conference
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
Subscribe To Our Newsletter & Stay Updated